Riskpilot← Back to searchSign inGet full accessMimebrain AB
ABActiveOrg 5591957153Södra Allén 31Medical specialists activities · NACE 8622Est. 20190 employees
Revenue 2024
SEK 1,7M
+534% vs 2023
EBITDA margin
95.5%
+720% vs 2023
Equity ratio
49.6%
Financial strength
Net profit 2024
SEK 1M
+706% vs 2023
| Revenue | SEK 1,7M | +534% |
| EBITDA | SEK 1,7M | +720% |
| Net profit | SEK 1M | +706% |
| Total assets | SEK 2,2M | +659% |
| Equity | SEK 1,1M | +589% |
| Employees | 0 | — |
Legal name
Mimebrain AB
Org number
5591957153
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
20 februari 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget producerar appar främst inriktade mot området social innovation.
Address
Södra Allén 31
Email
usama.mk@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | — | 0 | 272 | 1 728 |
| Staff expenses | — | — | — | −9 | −24 |
| EBITDA | −1 | 0 | −1 | 201 | 1 650 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −1 | 0 | −1 | 201 | 1 650 |
| Net financials | — | — | — | 0 | −1 |
| Profit before tax | −1 | 0 | −1 | 156 | 1 299 |
| Tax | −0 | — | — | −28 | −266 |
| Net profit | −1 | — | −1 | 128 | 1 033 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 49 | — | 47 | 290 | 2 201 |
| Equity | 49 | — | 30 | 158 | 1 091 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 0 | — | 17 | 87 | 715 |
| Total debt | — | — | 17 | 87 | 715 |
EBITDA margin
95.5%
This company
15.8%
Market median
+504% vs market
20202024
Equity ratio
49.6%
This company
38.2%
Market median
+30% vs market
20202024
Return on equity
94.6%
This company
18.4%
Market median
+414% vs market
20202024
Net profit margin
59.8%
This company
8.1%
Market median
+638% vs market
20202024
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
20202024
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
UM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mimebrain AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Usama Mustafa Kamil | Chief Executive Officer | 0 companies |
| Hanan Ahmedfoad Abdulkhalek | Deputy Board Member | 0 companies |
| Husein Mustafa Kamil | Board of Directors | 0 companies |